Your browser doesn't support javascript.
loading
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies.
Whaley, Rachael E; Ameny, Sarah; Arkatkar, Tanvi; Seese, Aaron; Wall, Abigail; Khan, Iram; Carter, Joseph J; Scherer, Erin M; Rawlings, David J; Galloway, Denise A; McElrath, M Juliana; Cohen, Kristen W; McGuire, Andrew T.
Afiliación
  • Whaley RE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ameny S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Arkatkar T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Seese A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Wall A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Khan I; Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA, USA.
  • Carter JJ; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Scherer EM; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Rawlings DJ; Center for Immunity and Immunotherapies and the Program for Cell and Gene Therapy, Seattle Children's Research Institute, Seattle, WA, USA; Departments of Pediatrics and Immunology, University of Washington, Seattle, WA, USA.
  • Galloway DA; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: kwcohen@fredhutch.org.
  • McGuire AT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Deparment of Laboratory Medicine and Pahthology, University of Washington, Seattle, WA, USA. Electronic address: amcguire@fredhu
J Immunol Methods ; 488: 112901, 2021 01.
Article en En | MEDLINE | ID: mdl-33069767
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoglobulina G / Linfocitos B / Separación Celular / Vacunas contra Papillomavirus / Anticuerpos Neutralizantes / Ensayos Analíticos de Alto Rendimiento / Anticuerpos Monoclonales / Anticuerpos Antivirales Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Adolescent / Adult / Animals / Female / Humans Idioma: En Revista: J Immunol Methods Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inmunoglobulina G / Linfocitos B / Separación Celular / Vacunas contra Papillomavirus / Anticuerpos Neutralizantes / Ensayos Analíticos de Alto Rendimiento / Anticuerpos Monoclonales / Anticuerpos Antivirales Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Adolescent / Adult / Animals / Female / Humans Idioma: En Revista: J Immunol Methods Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos